John Cox

Affiliations

  • Ceo & President at Dyne Therapeutics Inc. (DYN), 2025-06-06
  • at Sigilon Therapeutics Inc. (SGTX), 2023-08-11
  • Director at Repligen Corp (RGEN), 2020-03-26
  • Chief Executive Officer at Bioverativ Inc. (BIVV), 2018-03-08
  • Evp Pharmaceutical Oper & Tech at Biogen Inc. (BIIB), 2016-04-05
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DYN $33.09 7,200 $238,248.00 8,000 2024-09-04 Filing
DYN $32.57 800 $26,056.00 800 2024-09-04 Filing
DYN $33.09 7,200 $238,248.00 8,000 2024-09-04 Filing
DYN $32.57 800 $26,056.00 800 2024-09-04 Filing
DYN $33.09 7,200 $238,248.00 8,000 2024-09-04 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
DYN $13.35 4,060 $54,201.00 142,179 2025-06-05 Filing
DYN $11.83 4,061 $48,041.63 146,239 2025-03-05 Filing
RGEN $96.72 1,858 $179,705.76 923 2020-03-24 Filing
RGEN $97.17 1,016 $98,724.72 2,781 2020-03-18 Filing
RGEN $96.45 1,187 $114,486.15 3,797 2020-03-18 Filing